Thromb Haemost 2021; 121(12): 1637-1649
DOI: 10.1055/s-0041-1728763
Blood Cells, Inflammation and Infection

Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction

1   Department of Surgery and Anaesthesia, The University of Otago, Wellington, New Zealand
2   School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
3   Wellington Cardiovascular Research Group, Wellington, New Zealand
,
Olivia M. Parker
1   Department of Surgery and Anaesthesia, The University of Otago, Wellington, New Zealand
3   Wellington Cardiovascular Research Group, Wellington, New Zealand
,
Morgane M. Brunton-O'Sullivan
1   Department of Surgery and Anaesthesia, The University of Otago, Wellington, New Zealand
3   Wellington Cardiovascular Research Group, Wellington, New Zealand
,
Scott A. Harding
3   Wellington Cardiovascular Research Group, Wellington, New Zealand
4   Department of Cardiology, Wellington Regional Hospital, Wellington, New Zealand
,
Peter D. Larsen
1   Department of Surgery and Anaesthesia, The University of Otago, Wellington, New Zealand
2   School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
3   Wellington Cardiovascular Research Group, Wellington, New Zealand
› Author Affiliations
Funding K.E.H. is supported by the National Heart Foundation of New Zealand Postdoctoral Fellowship. This work was supported by a Dean's Research Grant from the University of Otago, Wellington, New Zealand.

Abstract

Background Activation of both platelets and neutrophils can contribute to the risk of major adverse cardiovascular events (MACE) following acute myocardial infarction (AMI). Neutrophil extracellular traps (NETs) are an important product of the platelet–neutrophil axis and exaggerate vascular damage in cardiovascular disease. Additionally, activated platelets can drive NETosis and are directly linked to thromboembolic risk. Investigating the combined effect of biomarkers for NETosis and platelet activation represents a novel approach to risk prediction post-AMI. Here, we examined the utility of a composite biomarker score, inclusive of both pathways, for predicting MACE post-AMI.

Methods and Results In a case–control design, 100 case patients who experienced MACE within 1 year of index admission were matched in a 1:2 ratio with control patients. Serum levels of myeloperoxidase–DNA, neutrophil elastase–DNA, and citrullinated histone H3 were assayed by enzyme-linked immunosorbent assay (ELISA) as markers of NET burden. To measure platelet activation, soluble P-selectin was assayed by ELISA in parallel. Platelet and neutrophil counts were also recorded. Composite biomarker scores, inclusive of biomarkers for NETosis and platelet activation, were assessed using multivariate regression modeling. These composite biomarker scores were independent predictors of 1-year MACE. The strongest association with MACE was observed using a composite of platelet count, soluble P-selectin, and all NET markers (odds ratio: 1.94; 1.16–3.25).

Conclusion Here, we demonstrate the importance of combining biomarkers of NETosis and platelet activation for risk prediction in patients with AMI. Combining biomarkers from closely linked, but distinct, biological pathways was more effective than utilizing either type of biomarker alone.

Supplementary Material



Publication History

Received: 03 February 2021

Accepted: 08 March 2021

Article published online:
13 May 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Fang L, Moore X-L, Dart AM, Wang L-M. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol 2015; 12 (03) 305-312
  • 2 Puhl S-L, Steffens S. Neutrophils in post-myocardial infarction inflammation: damage vs. resolution?. Front Cardiovasc Med 2019; 6: 25-25
  • 3 Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 1989; 80 (06) 1816-1827
  • 4 Chatelain P, Latour JG, Tran D, de Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 1987; 75 (05) 1083-1090
  • 5 Horckmans M, Ring L, Duchene J. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J 2017; 38 (03) 187-197
  • 6 Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int 2018; 93 (02) 365-374
  • 7 Söderberg D, Segelmark M. Neutrophil extracellular traps in ANCA-associated vasculitis. Front Immunol 2016; 7: 256
  • 8 Ge L, Zhou X, Ji WJ. et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am J Physiol Heart Circ Physiol 2015; 308 (05) H500-H509
  • 9 Vajen T, Koenen RR, Werner I. et al. Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis. Sci Rep 2018; 8 (01) 10647-10647
  • 10 Döring Y, Libby P, Soehnlein O. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res 2020; 126 (09) 1228-1241
  • 11 Silvestre-Roig C, Braster Q, Wichapong K. et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature 2019; 569 (7755): 236-240
  • 12 Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 2015; 349 (6245): 316-320
  • 13 Borissoff JI, Joosen IA, Versteylen MO. et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 2013; 33 (08) 2032-2040
  • 14 Langseth MS, Opstad TB, Bratseth V. et al. Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease. Eur J Prev Cardiol 2018; 25 (07) 762-769
  • 15 Mangold A, Alias S, Scherz T. et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res 2015; 116 (07) 1182-1192
  • 16 Liu J, Yang D, Wang X. et al. Neutrophil extracellular traps and dsDNA predict outcomes among patients with ST-elevation myocardial infarction. Sci Rep 2019; 9 (01) 11599
  • 17 Langseth MS, Helseth R, Ritschel V. et al. Double-stranded DNA and NETs components in relation to clinical outcome after ST-elevation myocardial infarction. Sci Rep 2020; 10 (01) 5007
  • 18 Hally KE, Danielson KM, Larsen PD. Looking to the future: spotlight on emerging biomarkers for predicting cardiovascular risk. Curr Epidemiol Rep 2018; 5 (03) 230-242
  • 19 Zucoloto AZ, Jenne CN. Platelet-neutrophil interplay: insights into neutrophil extracellular trap (NET)-driven coagulation in infection. Front Cardiovasc Med 2019; 6 (85) 85
  • 20 Fuchs TA, Brill A, Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107 (36) 15880-15885
  • 21 Wang Y, Luo L, Braun OÖ. et al. Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice. Sci Rep 2018; 8 (01) 4020
  • 22 Gould TJ, Vu TT, Swystun LL. et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol 2014; 34 (09) 1977-1984
  • 23 Valenti R, Marcucci R, Capodanno D. et al. Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study. J Thromb Thrombolysis 2015; 40 (01) 76-82
  • 24 Tantry US, Bonello L, Aradi D. et al; Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013; 62 (24) 2261-2273
  • 25 Price MJ, Endemann S, Gollapudi RR. et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008; 29 (08) 992-1000
  • 26 Badr Eslam R, Lang IM, Koppensteiner R, Calatzis A, Panzer S, Gremmel T. Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitors. Int J Cardiol 2013; 168 (01) 403-406
  • 27 Wadowski PP, Eichelberger B, Kopp CW. et al. Disaggregation following agonist-induced platelet activation in patients on dual antiplatelet therapy. J Cardiovasc Transl Res 2017; 10 (04) 359-367
  • 28 Hally KE, La Flamme AC, Harding SA, Larsen PD. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation: results of a randomized, cross-over trial. Platelets 2019; 30 (05) 599-607
  • 29 Granger CB, Goldberg RJ, Dabbous O. et al; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163 (19) 2345-2353
  • 30 Masuda S, Nakazawa D, Shida H. et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin Chim Acta 2016; 459: 89-93
  • 31 Kessenbrock K, Krumbholz M, Schönermarck U. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15 (06) 623-625
  • 32 Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD. P-selectin promotes neutrophil extracellular trap formation in mice. Blood 2015; 126 (02) 242-246
  • 33 Carestia A, Kaufman T, Rivadeneyra L. et al. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol 2016; 99 (01) 153-162
  • 34 Clark SR, Ma AC, Tavener SA. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13 (04) 463-469
  • 35 Maugeri N, Campana L, Gavina M. et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost 2014; 12 (12) 2074-2088
  • 36 Hoppenbrouwers T, Autar ASA, Sultan AR. et al. In vitro induction of NETosis: comprehensive live imaging comparison and systematic review. PLoS One 2017; 12 (05) e0176472
  • 37 Elaskalani O, Abdol Razak NB, Metharom P. Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones. Cell Commun Signal 2018; 16 (01) 24
  • 38 Ferroni P, Martini F, Riondino S. et al. Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta 2009; 399 (1–2): 88-91
  • 39 Body R, Pemberton P, Ali F. et al. Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction. Clin Chim Acta 2011; 412 (7–8): 614-618
  • 40 Dormann CF, Elith J, Bacher S. et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 2013; 36 (01) 27-46
  • 41 Ly HQ, Kirtane AJ, Murphy SA. et al; TIMI Study Group. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol 2006; 98 (01) 1-5
  • 42 Nikolsky E, Grines CL, Cox DA. et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007; 99 (08) 1055-1061
  • 43 Mueller C, Neumann FJ, Hochholzer W. et al. The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction. Am Heart J 2006; 151 (06) 1214.e1-1214.e7
  • 44 Xiang L, Wang M, You T, Jiao Y, Chen J, Xu W. Prognostic value of Ventricular Wall Motion score and Global Registry of Acute Coronary Events score in patients with acute myocardial infarction. Am J Med Sci 2017; 354 (01) 27-32
  • 45 Tang EW, Wong C-K, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007; 153 (01) 29-35
  • 46 Eagle KA, Lim MJ, Dabbous OH. et al; GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291 (22) 2727-2733